Which has grown faster, MRVI or UFPT?

Over the past five years, UFPT grew revenue faster — MRVI at a -17.68% CAGR versus UFPT at 27.47%.

Is MRVI or UFPT more profitable?

UFPT runs the higher net margin — MRVI at -37.07% versus UFPT at 11.45%.

How have MRVI and UFPT total returns compared?

Over the past 5 years, MRVI delivered -27.63% and UFPT delivered 37.11% annualized total return. Past performance doesn't predict future results.

Maravai LifeSciences Holdings, Inc. (MRVI) vs UFP Technologies, Inc. (UFPT)

A side-by-side comparison of Maravai LifeSciences Holdings, Inc. and UFP Technologies, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

MRVI

Maravai LifeSciences Holdings, Inc.

$2.24B

$8.12HealthcareDelayed quote: Oct 6, 2026, 2:20 PM EDT

UFPT

UFP Technologies, Inc.

$2.33B

$301.28HealthcareDelayed quote: Oct 6, 2026, 2:20 PM EDT

Total return — MRVI vs UFPT

growth of $100 · dividends reinvested · last 6y

MRVI -71.5% (-18.9%/yr)UFPT +601.7% (+38.4%/yr)UFPT compounded faster over this window

Log scale — wide-divergence pair

MRVI UFPT

MRVI vs UFPT: by the numbers

•UFPT is the larger company ($2.33B vs $2.24B market cap).
•UFPT is profitable (11.45% net margin) while MRVI runs a net loss (-37.07%).
•UFPT grew revenue faster over the past five years (27.47% vs -17.68% CAGR).

Metrics side by side

Valuation

Metric	MRVI	UFPT
P/E ratio	N/A	32.50
Forward P/E	N/A	30.92
PEG ratio	N/A	0.86
P/S ratio	10.74	3.69
P/B ratio	10.95	5.04
EV / EBITDA	15.51	20.44
FCF yield	N/A	2.64%

Profitability

Metric	MRVI	UFPT
Gross margin	17.98%	28.50%
Operating margin	-3.63%	15.25%
Net margin	-37.07%	11.45%
ROE	-37.82%	15.63%
ROIC	16.96%	12.75%

Growth (annualized)

Metric	MRVI	UFPT
Revenue CAGR (5Y)	-17.68%	27.47%
EPS CAGR (5Y)	N/A	37.73%
FCF CAGR (5Y)	N/A	26.87%
Total return CAGR (5Y)	-27.63%	37.11%

Frequently asked

Which has grown faster, MRVI or UFPT?: Over the past five years, UFPT grew revenue faster — MRVI at a -17.68% CAGR versus UFPT at 27.47%.
Is MRVI or UFPT more profitable?: UFPT runs the higher net margin — MRVI at -37.07% versus UFPT at 11.45%.
How have MRVI and UFPT total returns compared?: Over the past 5 years, MRVI delivered -27.63% and UFPT delivered 37.11% annualized total return. Past performance doesn't predict future results.

Go deeper

Full MRVI analysis Full UFPT analysis Interactive comparison tool

Dig into the metrics

UFP Technologies P/E ratio Maravai LifeSciences ROE UFP Technologies ROE Maravai LifeSciences operating margin UFP Technologies operating margin Maravai LifeSciences revenue growth UFP Technologies revenue growth Maravai LifeSciences free cash flow UFP Technologies free cash flow

Maravai LifeSciences & UFP Technologies appear in these rankings

Fastest Revenue Growth Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.